Owen LaRue’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6,035
Closed -$225K 123
2025
Q3
$225K Sell
6,035
-763
-11% -$27.7K 0.09% 106
2025
Q2
$248K Buy
+6,798
New +$246K 0.11% 95
2024
Q4
Sell
-5,875
Closed -$246K 92
2024
Q3
$246K Sell
5,875
-1,896
-24% -$78.7K 0.13% 84
2024
Q2
$317K Sell
7,771
-1,670
-18% -$66.5K 0.2% 67
2024
Q1
$391K Buy
9,441
+83
+0.9% +$3.48K 0.24% 56
2023
Q4
$379K Sell
9,358
-2,568
-22% -$98.1K 0.36% 50
2023
Q3
$467K Sell
11,926
-1,191
-9% -$47.4K 0.51% 45
2023
Q2
$528K Buy
13,117
+205
+2% +$8.44K 0.56% 42
2023
Q1
$557K Hold
12,912
0.6% 37
2022
Q4
$557K Buy
+12,912
New +$549K 0.6% 37

Other funds holding BME

Owen LaRue's BME Position: Q4 2025 in Review

Owen LaRue sold out of BlackRock Health Sciences Trust (BME) in Q4 2025, closing a stake of 6,035 shares — an estimated $225K sold.

Owen LaRue first reported a position in BME in Q4 2022 and held it in 10 quarters. The position peaked at $557K in Q1 2023. 77 funds tracked by Wall St. Rank hold BME as of Q4 2025.

  • Owen LaRue reported no remaining BlackRock Health Sciences Trust position as of Q4 2025 after selling out during the quarter.
  • Owen LaRue sold 6,035 BlackRock Health Sciences Trust shares in Q4 2025, an estimated $225K.
  • Owen LaRue first reported a position in BlackRock Health Sciences Trust in Q4 2022 and held it in 10 quarters.
  • Owen LaRue's BlackRock Health Sciences Trust position peaked at $557K in Q1 2023.
  • 77 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2025.

Based on Owen LaRue's 13F filing for Q4 2025, filed 5 Feb 2026.